HSGX Histogenics Corporation

1.75
+0  (1%)
Previous Close 1.73
Open 1.73
Price To book 2.63
Market Cap 36.13M
Shares 20,645,000
Volume 39,811
Short Ratio 0.84
Av. Daily Volume 157,705

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 top-line data due mid 2018.
NeoCart
Cartilage defects in the knee

Latest News

  1. Histogenics Corporation To Announce First Quarter 2017 Financial Results on May 11, 2017
  2. Histogenics Corporation to Present at 5th Annual Cell & Gene Therapy Investor Day on April 27, 2017
  3. Histogenics Corporation to Present at Needham & Company’s 16th Annual Healthcare Conference
  4. Edited Transcript of HSGX earnings conference call or presentation 16-Mar-17 12:30pm GMT
  5. Histogenics posts 4Q profit
  6. Histogenics Corporation Announces Financial and Operating Results for the Fourth Quarter and Year Ended December 31, 2016
  7. Histogenics Announces Publication of Biomechanical and Structural Data From Human Engineered Cartilage Testing
  8. Histogenics Corporation to Announce 2016 Financial Results on March 16, 2017
  9. Histogenics Corporation to Present at Upcoming Investor Conferences
  10. Will Thermo Fisher (TMO) Beat Earnings Estimates in Q4?
  11. Zimmer Biomet (ZBH) Q4 Earnings: A Surprise in the Cards?
  12. Quest Diagnostics (DGX) Q4 Earnings: What Lies in Store?
  13. ResMed (RMD) Q2 Earnings: Disappointment in the Cards?
  14. Stock Market Roundup, Jan. 12: AMZN Jobs, FCAU Cheating, AKS & X Tank
  15. Thursday’s Biggest Biopharma Winners
  16. Histogenics Corp (HSGX) Is Too Cheap To Pass Up For Hedgie Hal Mintz
  17. How Histogenics Corp (HSGX) Stacks Up Against Its Peers
  18. Edited Transcript of HSGX earnings conference call or presentation 10-Nov-16 1:30pm GMT